Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion

Eye (Lond). 2003 Aug;17(6):731-4. doi: 10.1038/sj.eye.6700495.

Abstract

Purpose: Retinal artery occlusion is a common vision-threatening disease. Among other risk factors, coagulopathies leading to a hypercoagulable state have been associated with retinal artery occlusion. Numerous studies have shown that two genetic variants, factor V Leiden and prothrombin 20210A, cause a procoagulant state. However, their role in the pathogenesis of retinal artery occlusion is still unclear. The purpose of the present study was therefore to investigate a possible association between factor V Leiden, prothrombin 20210A, and retinal artery occlusion.

Methods: In the present retrospective case-control study, we studied 136 patients with retinal artery occlusion and 136 age- and gender-matched control subjects. The presence of factor V Leiden and prothrombin 20210A alleles was determined by polymerase chain reaction.

Results: The prevalence of heterozygosity for the prothrombin G20210A variant did not significantly differ between patients and controls (three patients vs two controls, P=0.65). Distribution of factor V Leiden genotypes revealed no significant difference among the two groups (heterozygosity: eight patients vs 11 controls, P=0.47). As for other risk factors, arterial hypertension, a history of stroke and myocardial infarction were significantly more frequent in patients than in controls.

Conclusion: Our data suggest that factor V Leiden and prothrombin 20210A do not play a major role in patients with retinal artery occlusion.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Cardiovascular Diseases / complications
  • Case-Control Studies
  • Factor V / genetics*
  • Female
  • Genotype
  • Heterozygote
  • Humans
  • Male
  • Middle Aged
  • Prothrombin / genetics*
  • Retinal Artery Occlusion / etiology
  • Retinal Artery Occlusion / genetics*
  • Risk Factors

Substances

  • factor V Leiden
  • Factor V
  • Prothrombin